Age, yr | 28.1 ± 7.8 |
Sex, M/F | 25/17 |
Severity of CFTR genotype, S/M/ND | 30/4/8 |
BMI, Kg/m 2 | 17.8 ± 2.1 |
Extra-pulmonary involvement | |
Pancreatic insufficiency | 37 (88%) |
Diabetes | 8 (19%) |
Cirrhosis | 3 (7%) |
Chronic airway colonization | |
P. aeruginosa | 39 (93%) |
B. cepacia complex | 2 (5%) |
Lung function in stable state | |
FEV1, % predicted | 28 ± 12 |
FVC, % predicted | 45 ± 15 |
TLC, % predicted | 98 ± 22 |
Room air PaO2, mmHg | 62 ± 15 |
Room air PaCO2, mmHg | 47 ± 9 |
Room air SaO2, % | 89 ± 8 |
Annual FEV1 loss, % predicted/yr | 4.21 ± 2.65 |
Home ventilatory support | |
Long term oxygenotherapy alone | 12 (29%) |
Noninvasive ventilation | 10 (24%) |
Patients awaiting lung transplant | 9 (21%) |